Skip to content
TrialScanner

NCT04500587

Phase 1 First in Human Study of ZN-d5 as a Single Agent

Phase 1CompletedZNTLLead

Registry record

Lead sponsor
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
Conditions
Acute Myeloid Leukemia; Non Hodgkin Lymphoma
Primary completion
Dec 12, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04500587 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04500587: Phase 1 First in Human Study... | TrialScanner